title: In vivo administration of recombinant granulocyte colony stimulating factor corrects acquired neutrophil function deficiency association with chronic graft-versus-host disease.
authors.affiliation: Marrow Transplant Unit, Institut Paoli-Calmettes, Marseille, France.
authors.forename: A M
authors.initials: AM
authors.lastname: Stoppa
authors.forename: C
authors.initials: C
authors.lastname: Fossat
authors.forename: D
authors.initials: D
authors.lastname: Sainty
authors.forename: D
authors.initials: D
authors.lastname: Blaise
authors.forename: P
authors.initials: P
authors.lastname: Viens
authors.forename: D
authors.initials: D
authors.lastname: Baume
authors.forename: M
authors.initials: M
authors.lastname: Bayssas
authors.forename: I
authors.initials: I
authors.lastname: Juhan Vague
authors.forename: D
authors.initials: D
authors.lastname: Maraninchi
mesh_terms: D000328:Adult; D016026:Bone Marrow Transplantation; D002448:Cell Adhesion / Q000187:drug effects; D002634:Chemotaxis, Leukocyte / Q000187:drug effects; D005260:Female; D006086:Graft vs Host Disease / Q000150:complications*; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D009504:Neutrophils / Q000187:drug effects*; D009580:Nitroblue Tetrazolium / Q000032:analysis; D010587:Phagocytosis / Q000187:drug effects; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D009580:Nitroblue Tetrazolium